PREDICTION OF DRUG DISPOSITION BY HUMAN DRUG METABOLIZING ENZYMES

通过人体药物代谢酶预测药物分布

基本信息

  • 批准号:
    11557191
  • 负责人:
  • 金额:
    $ 3.01万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Drug oxidation activities of twelve recombinant human cytochrome P450 (P450) coexpressed with human NADPH-P450 reductase (NPR) in bacterial membranes (P450/NPR membranes) were determined and compared with those of other recombinant systems and of human liver microsomes. Addition of exogenous membrane-bound NPR to the P450/NPR membranes enhanced the catalytic activities of CYP2C8, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 ; however, enhancement of activities of CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2D6, and CYP2E1 in membranes was not observed after the addition of NPR in 4-molar excess to each P450. Exogenous purified human cytochrome b_5 (b_5) further enhanced catalytic activities of CYP2A6, CYP2B6, CYP2C8, CYP2E1, CYP3A4, and CYP3A5/NPR membranes. Catalytic activities of CYP2C9 and CYP2C19 were enhanced by addition of b_5 in reconstitution systems but not in the P450/NPR membranes. Apo b_5 (devoid of heme) enhanced catalytic activities when added to the both systems, except for CYP2E1/NPR membranes and the reconstituted systems containing purified CYP2C8 or CYP2E1 in comparison with b_5. Catalytic activities in P450/NPR membranes plus b_5 systems were roughly similar to those measured with microsomes of insect cells coexpressing P450 with NPR (and b_5) and/or of human liver microsomes, based on equivalent P450 contents. These results suggest that interactions of P450 and NPR coexpressed in membranes and reconstituted systems appear to be different in some human CYP2 family enzymes, possibly due to a conformational role of b_5. P450/NPR membrane systems containing b_5 are useful models for prediction of the rates for liver microsomal P450-dependent drug oxidations.
测定了12种与人NADPH-P450还原酶(NPR)共表达的重组人细胞色素P450 (P450)在细菌膜(P450/NPR膜)中的药物氧化活性,并与其他重组系统和人肝微粒体的药物氧化活性进行了比较。在P450/NPR膜上加入外源性膜结合NPR增强了CYP2C8、CYP2C9、CYP2C19、CYP3A4和CYP3A5的催化活性;然而,在每个P450中加入4摩尔过量的NPR后,没有观察到膜中CYP1A1、CYP1A2、CYP1B1、CYP2A6、CYP2B6、CYP2D6和CYP2E1的活性增强。外源性纯化的人细胞色素b_5 (b_5)进一步增强了CYP2A6、CYP2B6、CYP2C8、CYP2E1、CYP3A4和CYP3A5/NPR膜的催化活性。在重构体系中添加b_5可增强CYP2C9和CYP2C19的催化活性,而在P450/NPR膜中则无此作用。除了CYP2E1/NPR膜和含有纯化CYP2C8或CYP2E1的重组体系与b_5相比,两种体系中添加Apo b_5(不含血红素)均增强了催化活性。P450/NPR膜加b_5系统的催化活性与共表达P450与NPR(和b_5)的昆虫细胞微粒体和/或人肝微粒体的催化活性大致相似,基于等效的P450含量。这些结果表明,在一些人类CYP2家族酶中,P450和NPR在膜和重组系统中共表达的相互作用似乎是不同的,可能是由于b_5的构象作用。含有b_5的P450/NPR膜系统是预测肝微粒体P450依赖性药物氧化率的有用模型。

项目成果

期刊论文数量(48)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakajima M,et al.: "Azelastine N-demethylation by CYP3A4, CYP2D6, and CYP1A2 in human liver microsomes: Evaluation of approach to predict the contribution of multiple cytochrome P450s"Drug Metab Dispos. 27. 1381-1391 (1999)
Nakajima M 等人:“人肝微粒体中 CYP3A4、CYP2D6 和 CYP1A2 导致的氮卓斯汀 N-去甲基化:预测多种细胞色素 P450 贡献的方法评估”Drug Metab Dispos。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamazaki H,et al.: "Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P450 2C8 and P450 3A4 in human liver microsomes"Drug Metab Dispos. 27. 1260-1266 (1999)
Yamazaki H 等人:“人肝微粒体中细胞色素 P450 2C8 和 P450 3A4 催化曲格列酮氧化为醌型代谢物”Drug Metab Dispos。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMAZAKI Hiroshi其他文献

YAMAZAKI Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMAZAKI Hiroshi', 18)}}的其他基金

Relevance to bioactivation and toxicity of thalidomide, pomalidomide, and lenalidomide by human cytochrome P450 3A enzymes in cultured placental cells and humanized-liver mice
培养胎盘细胞和人源化肝小鼠中人细胞色素 P450 3A 酶与沙利度胺、泊马度胺和来那度胺生物活性和毒性的相关性
  • 批准号:
    17K08425
  • 财政年份:
    2017
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of resistance to molecularly targeted drugs for oral squamous cell carcinoma and investigation of countermeasures
口腔鳞癌分子靶向药物耐药机制及对策研究
  • 批准号:
    16K11732
  • 财政年份:
    2016
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Effective Markers for Resistance of Oral Squamous Cell Carcinoma to Molecular-targeting Drugs
口腔鳞状细胞癌分子靶向药物耐药性有效标志物的开发
  • 批准号:
    25463120
  • 财政年份:
    2013
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Thalidomide increases cytochrome P450 activity and drug metabolism in liver through direct activation of nuclear receptor CAR and PXR
沙利度胺通过直接激活核受体 CAR 和 PXR 增加肝脏细胞色素 P450 活性和药物代谢
  • 批准号:
    23590200
  • 财政年份:
    2011
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
evaluationofeffectivenessoftheobjectiveexaminationforautism indeafchildren
聋儿自闭症客观检查效果评价
  • 批准号:
    22791642
  • 财政年份:
    2010
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Role of cancer stem cells related molecules in oral squamous cell carcinoma
肿瘤干细胞相关分子在口腔鳞癌中的作用
  • 批准号:
    22592246
  • 财政年份:
    2010
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanism of chemical-induced toxicity in fetal livers
化学品致胎儿肝脏毒性的分子机制
  • 批准号:
    17390034
  • 财政年份:
    2005
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular Mechanisms of Toxic Expression Induced by Endocrine Disruptors via AHR
内分泌干​​扰物通过 AHR 诱导毒性表达的分子机制
  • 批准号:
    15390040
  • 财政年份:
    2003
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on the separation of rac and meso isomers and the reactivity of group 4 bridged metallocene complexes
外消旋和内消旋异构体的分离及第4族桥联茂金属配合物的反应性研究
  • 批准号:
    11640544
  • 财政年份:
    1999
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Creation of Substitution Labile Pyrazolylborate Metal Complexes
取代不稳定的吡唑基硼酸盐金属配合物的制备
  • 批准号:
    09640675
  • 财政年份:
    1997
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

In vitro biotransformation of cannabinoids using human liver microsomes
使用人肝微粒体对大麻素进行体外生物转化
  • 批准号:
    539958-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 3.01万
  • 项目类别:
    University Undergraduate Student Research Awards
The metabolism of phenprocoumon as influenced by genetic polymorphisms of the cytochrome P450 in human liver microsomes and recombinant enzymes
人肝微粒体细胞色素P450基因多态性和重组酶对苯丙香豆素代谢的影响
  • 批准号:
    5395659
  • 财政年份:
    2002
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Research Fellowships
CYP3A ISOFORMS MEDIATED ENANTIOSELECTIVE DRUG METABOLISM WITH HUMAN LIVER MICROSOMES
CYP3A 亚型介导的人肝微粒体对映选择性药物代谢
  • 批准号:
    06672286
  • 财政年份:
    1994
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了